Improvita Celebrates ZELSUVMI™ FDA Approval for the Treatment of Molluscum Contagiosum

MADISON, Wis., January 25, 2024 — Improvita, Inc., a Madison-based company affiliated with Innovenn, Inc., that focuses on human factors testing, ethnographic field research, user interface and user experience testing for medical devices, software as a medical device (SaMD), and combination drug/medical device products, is pleased to announce that its partner, Ligand Pharmaceuticals, has received […]

Improvita Successfully Completes Human Factors Validation Program Supporting Beyond Air’s LungFit® PH FDA Approval

MADISON, Wis., Aug. 16, 2022 /PRNewswire/ — Improvita, Inc., a Madison-based company affiliated with Innovenn, Inc., that focuses on human factors testing, ethnographic field research, user interface testing, and user experience testing for medical devices, software as a medical device, and combination drug / medical device products, is celebrating the approval of Beyond Air’s LungFit® […]